LENZ THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
LENZ THERAPEUTICS, INC. (LENZ) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.92 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-24
- LENZ THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $1.92M.
- LENZ THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $1.92M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2024-12-31 | $1.92M 10-K · filed 2026-03-24 | ||
| 2024-03-31 | $1.92M 10-Q · filed 2025-11-05 | ||
| 2024-03-22 | $1.90M 10-K · filed 2026-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |